|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date25 Jun 1965 |
Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
注射用盐酸椒苯酮胺用于治疗心力衰竭的随机、单盲、安慰剂平行对照探索性临床试验
[Translation] A randomized, single-blind, placebo-controlled exploratory clinical trial of piperphentonamine hydrochloride for injection in the treatment of heart failure
以安慰剂为对照,初步观察注射用盐酸椒苯酮胺对心力衰竭患者的心功能影响。
[Translation] Using placebo as control, this study preliminarily observed the effect of piperphentonamine hydrochloride injection on cardiac function in patients with heart failure.
注射用盐酸椒苯酮胺对心脏术后心力衰竭患者血流动力学影响的随机、单盲、安慰剂平行对照探索性临床试验
[Translation] A randomized, single-blind, placebo-controlled exploratory clinical trial on the effects of piperphentonamine hydrochloride injection on hemodynamics in patients with heart failure after cardiac surgery
(1)以安慰剂为对照,探索注射用盐酸椒苯酮胺对心脏外科手术后心力衰竭患者血流动力学影响。
(2)了解注射用盐酸椒苯酮胺用于心脏外科手术后心力衰竭患者的药代动力学(PK)/药效动力学(PD)特点,进一步评价给药方案。
[Translation] (1) Using placebo as control, explore the hemodynamic effects of piperphentonamine hydrochloride injection on patients with heart failure after cardiac surgery.
(2) Understand the pharmacokinetic (PK)/pharmacodynamic (PD) characteristics of piperphentonamine hydrochloride injection in patients with heart failure after cardiac surgery, and further evaluate the dosing regimen.
注射用盐酸椒苯酮胺对心脏术后心力衰竭患者血流动力学影响的随机、单盲、安慰剂平行对照探索性临床试验
[Translation] A randomized, single-blind, placebo-controlled exploratory clinical trial on the effects of piperphentonamine hydrochloride injection on hemodynamics in patients with heart failure after cardiac surgery
(1)以安慰剂为对照,探索注射用盐酸椒苯酮胺对心脏外科手术后心力衰竭患者血流动力学影响。 (2)了解注射用盐酸椒苯酮胺用于心脏外科手术后心力衰竭患者的药代动力学(PK)/药效动力学(PD)特点,进一步评价给药方案。
[Translation] (1) To explore the hemodynamic effects of piperphentonamine hydrochloride injection on patients with heart failure after cardiac surgery using placebo as control. (2) To understand the pharmacokinetic (PK)/pharmacodynamic (PD) characteristics of piperphentonamine hydrochloride injection in patients with heart failure after cardiac surgery and further evaluate the dosing regimen.
100 Clinical Results associated with Shanxi Fushenggong Pharmaceutical Group Co., Ltd.
0 Patents (Medical) associated with Shanxi Fushenggong Pharmaceutical Group Co., Ltd.
100 Deals associated with Shanxi Fushenggong Pharmaceutical Group Co., Ltd.
100 Translational Medicine associated with Shanxi Fushenggong Pharmaceutical Group Co., Ltd.